To study the effect of vidang taila Nasya and Goghrut Nasya in Migraine

Phase 3

Not yet recruiting

Conditions: Migraine with aura,

Registration Number: CTRI/2019/06/019755

Lead Sponsor: Pallavi Pandurang Vyavahare

Brief Summary: 1. Screening of patient of *Ardhavbhedak* will be done using a purposive sampling method. Followed by random sampling by lottery method, who meets the inclusion criteria, till the desired sample size is achieved.

2. 72 Patient of *Ardhavbhedak* will be purposively selected in OPD/IPD basis irrespective of of gender, economic status, religion, occupation.

3. 72 Patient will be allocated randomly into two groups-by Lottery methods.

4. Group A (Trial Group): 36 patients will be treated with *Vidang Taila Nasya* for 7 days Dose: 2 drops (1/2 ml) Group B (Control Group):36 patients will be treated with *Goghrita* *Nasya*For 7 days Dose: 2 drops (1/2 ml).

5. Criteria for assessment -

| |

| --- |

|subjective criteria will assess will be assessed with help of scoring pattern, Vas scale

Objective criteria will be assess with the help of Grading Pattern

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: All

Target Recruitment: 72

Inclusion Criteria

Patient suffering from symptoms of Ardhavbhedak i.e. Ardha Manya, Bhru, Shankha, Karna, Akshi, Lalat Ativedanam and Shastra Arni Nibha and Bhrama Patient between age group 20 to 60 yrs.
Patient of either gender.

Exclusion Criteria

Patients suffering from sinusitis systemic disorders like hypertension and dibetes Secondary headache caused by meningitis tumor encephalitis and refractive errors Pregnancy and lactation.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Subjective criteria ( by using Grades and Visual analogues Pain Scale)	21 days
Bhrama (giddiness)	21 days
Shatra Arni Nibha (Throbbing pain)	21 days
Unilateral severe pain affecting neck brow ear and orbital area forehead region	21 days
Objective criteria (by Gradation)	21 days
1 severity of headache	21 days
2 frequency of headache	21 days
3 duration of headache	21 days
4 Episode of Vomiting	21 days
4 Duration of Aura	21 days

Secondary Outcome Measures

Name	Time	Method
Study the concept of Ardhavbhedak and Migraine in details	Study the Nasya Kriyakalpa and its uses indications contra indications complications

Trial Locations

Locations (1): Sane Guruji Arogya Kendra
🇮🇳
Pune, MAHARASHTRA, India
Sane Guruji Arogya Kendra
🇮🇳Pune, MAHARASHTRA, India
Dr Pallavi Vyavahare
Principal investigator
7719921145
drpallavivyavhare24@gmail.com